
The possibility of combination therapy with atomoxetine (ATO) and oxybutynin (OXY) has been suggested for obstructive sleep apnoea (OSA). Overall, ATO–OXY therapy does not reduce AHI in Japanese OSA patients, although AHI was decreased in some patients. Future studies for identifying treatment response group characteristics are warranted.
Like
Save
Share